Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Arthritis, Rheumatoid | 114 | 2024 | 3712 | 19.260 |
Why?
|
Rheumatic Diseases | 39 | 2024 | 592 | 8.340 |
Why?
|
Antirheumatic Agents | 40 | 2024 | 1339 | 7.480 |
Why?
|
Lung Diseases, Interstitial | 22 | 2024 | 808 | 6.910 |
Why?
|
Rheumatology | 19 | 2023 | 576 | 4.110 |
Why?
|
Methotrexate | 13 | 2023 | 1727 | 2.160 |
Why?
|
Hydroxychloroquine | 11 | 2021 | 412 | 1.890 |
Why?
|
Rheumatoid Factor | 8 | 2023 | 188 | 1.860 |
Why?
|
Smoking | 22 | 2024 | 8987 | 1.760 |
Why?
|
Lupus Erythematosus, Systemic | 20 | 2023 | 2104 | 1.670 |
Why?
|
Arthritis, Psoriatic | 5 | 2023 | 215 | 1.610 |
Why?
|
Bronchiectasis | 2 | 2022 | 128 | 1.490 |
Why?
|
Pulmonary Disease, Chronic Obstructive | 7 | 2023 | 3047 | 1.390 |
Why?
|
Nurses | 16 | 2023 | 2461 | 1.350 |
Why?
|
Autoimmune Diseases | 8 | 2024 | 2133 | 1.310 |
Why?
|
Biological Products | 7 | 2023 | 860 | 1.270 |
Why?
|
Risk Factors | 73 | 2023 | 72290 | 1.240 |
Why?
|
Sarcoidosis | 3 | 2019 | 506 | 1.190 |
Why?
|
Women's Health | 4 | 2021 | 2034 | 1.190 |
Why?
|
Health Behavior | 5 | 2022 | 2636 | 1.140 |
Why?
|
Asthma | 8 | 2023 | 6011 | 1.120 |
Why?
|
Tobacco Smoke Pollution | 3 | 2021 | 816 | 1.110 |
Why?
|
Autoantibodies | 13 | 2023 | 2035 | 1.100 |
Why?
|
Risk Reduction Behavior | 4 | 2021 | 1125 | 1.010 |
Why?
|
Humans | 212 | 2024 | 744343 | 1.000 |
Why?
|
Sinusitis | 3 | 2024 | 923 | 0.990 |
Why?
|
Middle Aged | 106 | 2024 | 213383 | 0.960 |
Why?
|
Incidence | 31 | 2022 | 20947 | 0.900 |
Why?
|
Bone Diseases | 2 | 2019 | 416 | 0.880 |
Why?
|
Arthritis | 2 | 2020 | 659 | 0.880 |
Why?
|
Case-Control Studies | 26 | 2024 | 21746 | 0.870 |
Why?
|
Female | 125 | 2024 | 380194 | 0.860 |
Why?
|
Gout | 4 | 2022 | 573 | 0.850 |
Why?
|
Glucocorticoids | 10 | 2023 | 2107 | 0.800 |
Why?
|
Prospective Studies | 43 | 2024 | 53288 | 0.760 |
Why?
|
Patient Education as Topic | 4 | 2019 | 2278 | 0.730 |
Why?
|
Psoriasis | 3 | 2023 | 898 | 0.700 |
Why?
|
Smoking Cessation | 4 | 2019 | 2071 | 0.690 |
Why?
|
Male | 87 | 2024 | 350118 | 0.680 |
Why?
|
Adult | 77 | 2023 | 214055 | 0.680 |
Why?
|
Antimalarials | 3 | 2020 | 905 | 0.670 |
Why?
|
Sarcoidosis, Pulmonary | 1 | 2019 | 43 | 0.670 |
Why?
|
Mucin-5B | 4 | 2023 | 141 | 0.650 |
Why?
|
Air Pollution | 2 | 2023 | 2286 | 0.620 |
Why?
|
Air Pollutants | 2 | 2023 | 2817 | 0.610 |
Why?
|
Life Style | 6 | 2022 | 3835 | 0.600 |
Why?
|
Gastrointestinal Agents | 1 | 2021 | 494 | 0.580 |
Why?
|
Pneumonia | 2 | 2020 | 2133 | 0.560 |
Why?
|
Contraceptives, Oral, Hormonal | 1 | 2018 | 188 | 0.560 |
Why?
|
Risk Assessment | 21 | 2021 | 23338 | 0.560 |
Why?
|
Respiratory Mucosa | 1 | 2020 | 427 | 0.560 |
Why?
|
Public Opinion | 1 | 2020 | 477 | 0.560 |
Why?
|
Peptides, Cyclic | 4 | 2022 | 400 | 0.550 |
Why?
|
Sulfasalazine | 1 | 2016 | 79 | 0.550 |
Why?
|
Coronavirus Infections | 8 | 2021 | 3133 | 0.540 |
Why?
|
Immunosuppressive Agents | 4 | 2022 | 4149 | 0.530 |
Why?
|
Seafood | 1 | 2019 | 384 | 0.530 |
Why?
|
Drug Monitoring | 1 | 2021 | 956 | 0.530 |
Why?
|
Fusarium | 1 | 2015 | 51 | 0.520 |
Why?
|
Bariatric Surgery | 3 | 2020 | 952 | 0.520 |
Why?
|
Health Knowledge, Attitudes, Practice | 3 | 2018 | 3923 | 0.520 |
Why?
|
Gastritis | 1 | 2017 | 196 | 0.520 |
Why?
|
Autoimmunity | 2 | 2023 | 1349 | 0.510 |
Why?
|
Aged | 48 | 2024 | 163280 | 0.510 |
Why?
|
Environmental Exposure | 4 | 2020 | 4234 | 0.510 |
Why?
|
Lung Transplantation | 1 | 2023 | 1153 | 0.510 |
Why?
|
Health Education | 2 | 2018 | 1056 | 0.510 |
Why?
|
Registries | 11 | 2023 | 8089 | 0.510 |
Why?
|
Granuloma | 1 | 2017 | 319 | 0.500 |
Why?
|
Diet | 6 | 2019 | 7939 | 0.500 |
Why?
|
Endoscopy, Digestive System | 1 | 2017 | 345 | 0.490 |
Why?
|
Family | 2 | 2016 | 3147 | 0.480 |
Why?
|
Pneumonia, Viral | 7 | 2020 | 3240 | 0.480 |
Why?
|
Antiviral Agents | 3 | 2021 | 2987 | 0.470 |
Why?
|
Lung | 9 | 2023 | 9856 | 0.450 |
Why?
|
Monitoring, Physiologic | 1 | 2021 | 1738 | 0.440 |
Why?
|
Vaccination | 12 | 2024 | 3278 | 0.410 |
Why?
|
Cardiovascular Diseases | 8 | 2021 | 15165 | 0.410 |
Why?
|
Proportional Hazards Models | 13 | 2021 | 12354 | 0.400 |
Why?
|
Time Factors | 17 | 2023 | 40075 | 0.400 |
Why?
|
Arthritis, Infectious | 1 | 2015 | 367 | 0.400 |
Why?
|
Antibodies, Antinuclear | 4 | 2021 | 326 | 0.390 |
Why?
|
Periodicals as Topic | 1 | 2022 | 1432 | 0.380 |
Why?
|
Myositis | 2 | 2023 | 251 | 0.360 |
Why?
|
Disease Progression | 10 | 2023 | 13284 | 0.360 |
Why?
|
Respiratory Function Tests | 4 | 2023 | 1616 | 0.350 |
Why?
|
United States | 28 | 2023 | 69872 | 0.350 |
Why?
|
Exercise | 4 | 2022 | 5615 | 0.350 |
Why?
|
Severity of Illness Index | 7 | 2022 | 15540 | 0.350 |
Why?
|
Retrospective Studies | 16 | 2024 | 77449 | 0.350 |
Why?
|
Logistic Models | 9 | 2022 | 13408 | 0.340 |
Why?
|
Lung Diseases | 1 | 2019 | 1886 | 0.340 |
Why?
|
Sex Factors | 7 | 2021 | 10397 | 0.330 |
Why?
|
Obesity | 6 | 2020 | 12745 | 0.330 |
Why?
|
Fatty Acids, Omega-3 | 1 | 2018 | 1344 | 0.320 |
Why?
|
Environment | 1 | 2014 | 1124 | 0.320 |
Why?
|
Serologic Tests | 2 | 2021 | 374 | 0.310 |
Why?
|
Protein Tyrosine Phosphatase, Non-Receptor Type 22 | 2 | 2019 | 65 | 0.310 |
Why?
|
Physicians | 2 | 2023 | 4567 | 0.310 |
Why?
|
Renal Insufficiency, Chronic | 1 | 2021 | 2208 | 0.300 |
Why?
|
Antibodies, Monoclonal | 2 | 2024 | 9274 | 0.300 |
Why?
|
Prednisone | 5 | 2023 | 1574 | 0.300 |
Why?
|
Connective Tissue Diseases | 2 | 2020 | 264 | 0.290 |
Why?
|
Body Weight | 1 | 2017 | 4669 | 0.290 |
Why?
|
Musculoskeletal Diseases | 2 | 2023 | 581 | 0.290 |
Why?
|
Body Mass Index | 9 | 2021 | 12720 | 0.280 |
Why?
|
Prevalence | 6 | 2023 | 15226 | 0.270 |
Why?
|
Immunologic Factors | 3 | 2024 | 1580 | 0.270 |
Why?
|
Cohort Studies | 19 | 2024 | 40561 | 0.260 |
Why?
|
Genetic Predisposition to Disease | 9 | 2023 | 17446 | 0.260 |
Why?
|
Pandemics | 10 | 2023 | 8388 | 0.260 |
Why?
|
Lung Neoplasms | 3 | 2024 | 13102 | 0.250 |
Why?
|
Double-Blind Method | 6 | 2021 | 12026 | 0.250 |
Why?
|
Risk | 4 | 2021 | 9687 | 0.240 |
Why?
|
Research Design | 4 | 2022 | 5987 | 0.240 |
Why?
|
Remission Induction | 3 | 2021 | 2386 | 0.240 |
Why?
|
Antibodies, Viral | 6 | 2024 | 3176 | 0.230 |
Why?
|
Bone and Bones | 1 | 2014 | 2575 | 0.230 |
Why?
|
Age Factors | 7 | 2020 | 18370 | 0.220 |
Why?
|
Leukocytes, Mononuclear | 2 | 2022 | 1836 | 0.220 |
Why?
|
Folic Acid | 2 | 2021 | 1300 | 0.220 |
Why?
|
Paraneoplastic Syndromes | 1 | 2024 | 151 | 0.210 |
Why?
|
Influenza, Human | 1 | 2013 | 1479 | 0.210 |
Why?
|
Odds Ratio | 6 | 2022 | 9849 | 0.210 |
Why?
|
Receptors, Interleukin-6 | 1 | 2023 | 224 | 0.200 |
Why?
|
Hospitalization | 8 | 2022 | 10262 | 0.200 |
Why?
|
Oral Health | 2 | 2019 | 472 | 0.200 |
Why?
|
Lymphoma, T-Cell, Peripheral | 1 | 2023 | 134 | 0.200 |
Why?
|
Depression | 1 | 2021 | 7766 | 0.190 |
Why?
|
Myasthenia Gravis | 1 | 2023 | 199 | 0.190 |
Why?
|
Lymphoma, T-Cell | 1 | 2023 | 299 | 0.190 |
Why?
|
Inflammation | 4 | 2022 | 10638 | 0.190 |
Why?
|
Anti-Inflammatory Agents, Non-Steroidal | 3 | 2020 | 2282 | 0.190 |
Why?
|
Promoter Regions, Genetic | 2 | 2022 | 5867 | 0.180 |
Why?
|
Interleukin-12 | 1 | 2023 | 579 | 0.180 |
Why?
|
Alcohol Drinking | 3 | 2020 | 3966 | 0.180 |
Why?
|
Treatment Outcome | 9 | 2023 | 63114 | 0.180 |
Why?
|
Premature Birth | 2 | 2023 | 1721 | 0.170 |
Why?
|
Emphysema | 1 | 2022 | 247 | 0.170 |
Why?
|
Thorax | 1 | 2022 | 547 | 0.170 |
Why?
|
Comorbidity | 7 | 2021 | 10388 | 0.170 |
Why?
|
Postmenopause | 2 | 2018 | 2461 | 0.170 |
Why?
|
Vaccines, Synthetic | 1 | 2022 | 634 | 0.170 |
Why?
|
Immunity, Humoral | 1 | 2023 | 598 | 0.170 |
Why?
|
Antiphospholipid Syndrome | 1 | 2020 | 173 | 0.170 |
Why?
|
Macrophage Activation | 1 | 2022 | 558 | 0.170 |
Why?
|
Health Surveys | 3 | 2019 | 4037 | 0.160 |
Why?
|
Spirometry | 1 | 2021 | 864 | 0.160 |
Why?
|
Immunocompromised Host | 2 | 2020 | 847 | 0.160 |
Why?
|
Nutritive Value | 1 | 2021 | 339 | 0.160 |
Why?
|
Kidney Transplantation | 1 | 2013 | 4251 | 0.160 |
Why?
|
Granzymes | 1 | 2019 | 271 | 0.160 |
Why?
|
Multicenter Studies as Topic | 1 | 2023 | 1677 | 0.160 |
Why?
|
Area Under Curve | 3 | 2021 | 1654 | 0.160 |
Why?
|
Aged, 80 and over | 10 | 2022 | 57776 | 0.160 |
Why?
|
Diet Surveys | 2 | 2021 | 1173 | 0.160 |
Why?
|
Idiopathic Pulmonary Fibrosis | 1 | 2023 | 451 | 0.160 |
Why?
|
Steroids | 1 | 2023 | 930 | 0.150 |
Why?
|
Diagnosis, Differential | 3 | 2019 | 12959 | 0.150 |
Why?
|
Scleroderma, Systemic | 1 | 2021 | 323 | 0.150 |
Why?
|
Respiration, Artificial | 4 | 2022 | 2569 | 0.150 |
Why?
|
Lung Injury | 1 | 2022 | 436 | 0.150 |
Why?
|
Multivariate Analysis | 6 | 2020 | 12245 | 0.150 |
Why?
|
Occupational Therapy | 1 | 2019 | 134 | 0.150 |
Why?
|
Obesity, Abdominal | 1 | 2020 | 361 | 0.150 |
Why?
|
Mass Media | 1 | 2020 | 305 | 0.150 |
Why?
|
Follow-Up Studies | 6 | 2019 | 39050 | 0.150 |
Why?
|
Demography | 1 | 2022 | 1656 | 0.150 |
Why?
|
Medical History Taking | 1 | 2021 | 783 | 0.150 |
Why?
|
Sweden | 1 | 2020 | 1345 | 0.140 |
Why?
|
Metabolome | 2 | 2020 | 895 | 0.140 |
Why?
|
Drug Therapy, Combination | 4 | 2023 | 6489 | 0.140 |
Why?
|
Interinstitutional Relations | 1 | 2018 | 241 | 0.140 |
Why?
|
Citrulline | 1 | 2016 | 105 | 0.140 |
Why?
|
Viral Vaccines | 1 | 2022 | 636 | 0.140 |
Why?
|
Military Medicine | 1 | 2018 | 176 | 0.140 |
Why?
|
Life Change Events | 1 | 2021 | 938 | 0.140 |
Why?
|
Biological Specimen Banks | 1 | 2021 | 711 | 0.140 |
Why?
|
Cyclooxygenase 2 | 1 | 2018 | 611 | 0.140 |
Why?
|
Sleep Deprivation | 1 | 2022 | 832 | 0.140 |
Why?
|
Chemokines | 1 | 2020 | 970 | 0.130 |
Why?
|
Myocarditis | 1 | 2023 | 771 | 0.130 |
Why?
|
Epidemiologic Studies | 1 | 2019 | 676 | 0.130 |
Why?
|
Communication | 2 | 2020 | 3749 | 0.130 |
Why?
|
Rheumatic Fever | 1 | 2015 | 71 | 0.130 |
Why?
|
Osteonecrosis | 1 | 2017 | 227 | 0.130 |
Why?
|
Proton Pump Inhibitors | 1 | 2020 | 526 | 0.130 |
Why?
|
Prognosis | 3 | 2021 | 29063 | 0.130 |
Why?
|
Needs Assessment | 2 | 2019 | 1147 | 0.130 |
Why?
|
Military Personnel | 2 | 2021 | 1133 | 0.130 |
Why?
|
Carpal Tunnel Syndrome | 1 | 2018 | 300 | 0.130 |
Why?
|
Arginine | 1 | 2018 | 944 | 0.130 |
Why?
|
HLA Antigens | 1 | 2020 | 1381 | 0.130 |
Why?
|
Physical Therapy Modalities | 1 | 2019 | 550 | 0.130 |
Why?
|
Publishing | 1 | 2022 | 833 | 0.120 |
Why?
|
Fibrinogen | 1 | 2018 | 894 | 0.120 |
Why?
|
Delayed Diagnosis | 1 | 2018 | 441 | 0.120 |
Why?
|
HLA-B27 Antigen | 1 | 2014 | 76 | 0.120 |
Why?
|
Complementary Therapies | 1 | 2019 | 486 | 0.120 |
Why?
|
Genes, MHC Class II | 1 | 2015 | 457 | 0.120 |
Why?
|
Algorithms | 3 | 2020 | 13881 | 0.120 |
Why?
|
Nausea | 1 | 2017 | 673 | 0.120 |
Why?
|
Gastric Mucosa | 1 | 2017 | 599 | 0.120 |
Why?
|
Hematinics | 1 | 2017 | 281 | 0.120 |
Why?
|
Vomiting | 1 | 2017 | 636 | 0.120 |
Why?
|
Glomerular Filtration Rate | 1 | 2021 | 2170 | 0.120 |
Why?
|
Amino Acids | 2 | 2021 | 1736 | 0.120 |
Why?
|
Fibrosis | 1 | 2021 | 2029 | 0.120 |
Why?
|
Biomedical Research | 2 | 2020 | 3309 | 0.120 |
Why?
|
Carotenoids | 1 | 2017 | 624 | 0.110 |
Why?
|
Epitopes | 2 | 2017 | 2571 | 0.110 |
Why?
|
Aminolevulinic Acid | 1 | 2014 | 142 | 0.110 |
Why?
|
Endosonography | 1 | 2017 | 610 | 0.110 |
Why?
|
Overweight | 2 | 2014 | 2371 | 0.110 |
Why?
|
Carbonated Beverages | 1 | 2014 | 214 | 0.110 |
Why?
|
Hormone Replacement Therapy | 1 | 2018 | 745 | 0.110 |
Why?
|
CD8-Positive T-Lymphocytes | 2 | 2023 | 4479 | 0.110 |
Why?
|
Spondylitis, Ankylosing | 1 | 2014 | 156 | 0.110 |
Why?
|
Research Personnel | 1 | 2018 | 573 | 0.110 |
Why?
|
Neoplasms | 1 | 2022 | 21683 | 0.110 |
Why?
|
Mentors | 1 | 2018 | 631 | 0.110 |
Why?
|
Young Adult | 9 | 2022 | 56430 | 0.110 |
Why?
|
Physical Examination | 1 | 2019 | 1237 | 0.110 |
Why?
|
Antibody Formation | 3 | 2023 | 1402 | 0.110 |
Why?
|
Rare Diseases | 1 | 2017 | 553 | 0.110 |
Why?
|
Dietary Sucrose | 1 | 2014 | 246 | 0.100 |
Why?
|
Upper Extremity | 1 | 2017 | 648 | 0.100 |
Why?
|
Age of Onset | 1 | 2019 | 3271 | 0.100 |
Why?
|
Up-Regulation | 1 | 2021 | 4217 | 0.100 |
Why?
|
Information Dissemination | 1 | 2020 | 1099 | 0.100 |
Why?
|
Weight Gain | 2 | 2022 | 2292 | 0.100 |
Why?
|
Gastrectomy | 1 | 2015 | 663 | 0.100 |
Why?
|
Cytokines | 3 | 2022 | 7322 | 0.100 |
Why?
|
Respiratory Tract Diseases | 1 | 2016 | 722 | 0.090 |
Why?
|
Cause of Death | 1 | 2021 | 3584 | 0.090 |
Why?
|
Cross-Sectional Studies | 5 | 2023 | 25043 | 0.090 |
Why?
|
Hypersensitivity | 1 | 2019 | 1102 | 0.090 |
Why?
|
Arrhythmias, Cardiac | 1 | 2020 | 2268 | 0.090 |
Why?
|
China | 3 | 2020 | 2248 | 0.090 |
Why?
|
Health Communication | 1 | 2013 | 214 | 0.090 |
Why?
|
Menopause | 1 | 2017 | 1626 | 0.090 |
Why?
|
Ultraviolet Rays | 1 | 2014 | 1060 | 0.090 |
Why?
|
Hospitals, Teaching | 1 | 2014 | 1179 | 0.090 |
Why?
|
Polymorphism, Single Nucleotide | 2 | 2020 | 15519 | 0.090 |
Why?
|
Lower Extremity | 1 | 2017 | 1158 | 0.090 |
Why?
|
Chloroquine | 2 | 2020 | 280 | 0.080 |
Why?
|
Genome-Wide Association Study | 3 | 2023 | 12261 | 0.080 |
Why?
|
Azithromycin | 2 | 2020 | 196 | 0.080 |
Why?
|
Phenotype | 3 | 2017 | 16365 | 0.080 |
Why?
|
Kidney | 2 | 2021 | 7186 | 0.080 |
Why?
|
Antidepressive Agents | 1 | 2021 | 2838 | 0.080 |
Why?
|
Coronary Artery Disease | 2 | 2018 | 6487 | 0.080 |
Why?
|
Motivation | 1 | 2018 | 1971 | 0.080 |
Why?
|
Survival Analysis | 2 | 2017 | 10252 | 0.080 |
Why?
|
C-Reactive Protein | 2 | 2018 | 3778 | 0.080 |
Why?
|
Molecular Targeted Therapy | 1 | 2019 | 2727 | 0.080 |
Why?
|
Kaplan-Meier Estimate | 1 | 2018 | 6538 | 0.080 |
Why?
|
Patient Care Team | 1 | 2019 | 2531 | 0.070 |
Why?
|
Recurrence | 1 | 2019 | 8340 | 0.070 |
Why?
|
Disease | 1 | 2013 | 680 | 0.070 |
Why?
|
Gastric Bypass | 1 | 2015 | 812 | 0.070 |
Why?
|
Inflammatory Bowel Diseases | 1 | 2021 | 2425 | 0.070 |
Why?
|
Inflammation Mediators | 1 | 2015 | 1889 | 0.070 |
Why?
|
T-Lymphocytes | 1 | 2024 | 10180 | 0.070 |
Why?
|
Insurance, Health | 1 | 2018 | 2494 | 0.070 |
Why?
|
Referral and Consultation | 1 | 2019 | 3528 | 0.070 |
Why?
|
Education, Medical, Graduate | 1 | 2018 | 2291 | 0.070 |
Why?
|
Carcinoma, Non-Small-Cell Lung | 1 | 2024 | 5221 | 0.060 |
Why?
|
Intestines | 1 | 2014 | 1924 | 0.060 |
Why?
|
Alleles | 3 | 2024 | 6933 | 0.060 |
Why?
|
International Classification of Diseases | 2 | 2023 | 867 | 0.060 |
Why?
|
Melanoma | 1 | 2023 | 5510 | 0.060 |
Why?
|
Anti-Inflammatory Agents | 1 | 2014 | 1790 | 0.060 |
Why?
|
Weight Loss | 1 | 2015 | 2622 | 0.060 |
Why?
|
Clinical Trials as Topic | 1 | 2020 | 7913 | 0.060 |
Why?
|
Socioeconomic Factors | 2 | 2014 | 7785 | 0.060 |
Why?
|
Laparoscopy | 1 | 2015 | 2151 | 0.060 |
Why?
|
Gene Expression Regulation | 2 | 2019 | 12072 | 0.060 |
Why?
|
Child | 4 | 2023 | 77709 | 0.060 |
Why?
|
Electronic Health Records | 1 | 2020 | 4468 | 0.060 |
Why?
|
Anti-Bacterial Agents | 1 | 2021 | 7181 | 0.060 |
Why?
|
Endemic Diseases | 1 | 2023 | 182 | 0.050 |
Why?
|
Boston | 1 | 2015 | 9313 | 0.050 |
Why?
|
Atherosclerosis | 1 | 2018 | 3445 | 0.050 |
Why?
|
Adolescent | 6 | 2023 | 85781 | 0.050 |
Why?
|
Ireland | 1 | 2022 | 161 | 0.050 |
Why?
|
Biopsy | 1 | 2014 | 6756 | 0.050 |
Why?
|
Analgesics, Opioid | 1 | 2018 | 3674 | 0.050 |
Why?
|
Models, Structural | 1 | 2022 | 361 | 0.050 |
Why?
|
Ritonavir | 1 | 2023 | 322 | 0.050 |
Why?
|
Prednisolone | 1 | 2022 | 334 | 0.050 |
Why?
|
B-Cell Activating Factor | 1 | 2021 | 119 | 0.050 |
Why?
|
Synovial Fluid | 1 | 2023 | 394 | 0.050 |
Why?
|
Fabaceae | 1 | 2021 | 103 | 0.050 |
Why?
|
Putrescine | 1 | 2020 | 40 | 0.050 |
Why?
|
Databases, Factual | 3 | 2021 | 7729 | 0.050 |
Why?
|
Spermidine | 1 | 2020 | 56 | 0.050 |
Why?
|
Butyric Acid | 1 | 2020 | 55 | 0.050 |
Why?
|
Xenobiotics | 1 | 2021 | 73 | 0.050 |
Why?
|
Vital Capacity | 1 | 2023 | 925 | 0.050 |
Why?
|
Spondylarthropathies | 1 | 2020 | 14 | 0.050 |
Why?
|
Tomography, X-Ray Computed | 2 | 2020 | 20129 | 0.050 |
Why?
|
Phosphatidylethanolamines | 1 | 2020 | 134 | 0.050 |
Why?
|
Ki-67 Antigen | 1 | 2022 | 644 | 0.050 |
Why?
|
Caprylates | 1 | 2020 | 111 | 0.050 |
Why?
|
Genetic Variation | 1 | 2015 | 6544 | 0.050 |
Why?
|
Magnetic Resonance Imaging | 2 | 2017 | 35421 | 0.040 |
Why?
|
Receptors, Fc | 1 | 2023 | 541 | 0.040 |
Why?
|
Tumor Necrosis Factor-alpha | 2 | 2023 | 4420 | 0.040 |
Why?
|
Carnitine | 1 | 2020 | 246 | 0.040 |
Why?
|
Azetidines | 1 | 2020 | 142 | 0.040 |
Why?
|
Translations | 1 | 2019 | 64 | 0.040 |
Why?
|
Nuts | 1 | 2021 | 257 | 0.040 |
Why?
|
Interleukin 1 Receptor Antagonist Protein | 1 | 2020 | 297 | 0.040 |
Why?
|
Synovial Membrane | 1 | 2022 | 507 | 0.040 |
Why?
|
Immunophenotyping | 1 | 2023 | 1880 | 0.040 |
Why?
|
Blood Urea Nitrogen | 1 | 2018 | 191 | 0.040 |
Why?
|
Cyclooxygenase 1 | 1 | 2018 | 104 | 0.040 |
Why?
|
Chromosomal Proteins, Non-Histone | 1 | 2024 | 736 | 0.040 |
Why?
|
Tryptophan | 1 | 2020 | 478 | 0.040 |
Why?
|
Forced Expiratory Volume | 1 | 2023 | 1743 | 0.040 |
Why?
|
T-Lymphocytes, Helper-Inducer | 1 | 2024 | 986 | 0.040 |
Why?
|
Linear Models | 2 | 2020 | 5952 | 0.040 |
Why?
|
Methionine | 1 | 2020 | 590 | 0.040 |
Why?
|
Diet Records | 1 | 2019 | 425 | 0.040 |
Why?
|
Reproducibility of Results | 3 | 2021 | 19905 | 0.040 |
Why?
|
Transaminases | 1 | 2018 | 199 | 0.040 |
Why?
|
Interleukins | 1 | 2022 | 791 | 0.040 |
Why?
|
Longitudinal Studies | 3 | 2020 | 13989 | 0.040 |
Why?
|
Telomere | 1 | 2024 | 910 | 0.040 |
Why?
|
Self Report | 2 | 2022 | 3558 | 0.040 |
Why?
|
Muscular Diseases | 1 | 2022 | 556 | 0.040 |
Why?
|
Massachusetts | 2 | 2020 | 8663 | 0.040 |
Why?
|
Infant, Newborn | 3 | 2023 | 25625 | 0.040 |
Why?
|
Myocardial Infarction | 1 | 2018 | 11727 | 0.040 |
Why?
|
Purines | 1 | 2020 | 594 | 0.040 |
Why?
|
Beer | 1 | 2017 | 127 | 0.040 |
Why?
|
Phosphofructokinase-2 | 1 | 2016 | 32 | 0.040 |
Why?
|
DNA | 2 | 2021 | 7301 | 0.040 |
Why?
|
Cross-Over Studies | 1 | 2022 | 2029 | 0.040 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2018 | 320 | 0.040 |
Why?
|
Wine | 1 | 2017 | 165 | 0.040 |
Why?
|
Pregnant Women | 1 | 2021 | 568 | 0.040 |
Why?
|
Waist Circumference | 1 | 2020 | 917 | 0.030 |
Why?
|
Immunoglobulins, Intravenous | 1 | 2020 | 652 | 0.030 |
Why?
|
Vasculitis | 1 | 2020 | 519 | 0.030 |
Why?
|
T-Lymphocytes, Cytotoxic | 1 | 2023 | 1821 | 0.030 |
Why?
|
Interleukin-10 | 1 | 2021 | 1200 | 0.030 |
Why?
|
Kinetics | 1 | 2024 | 6473 | 0.030 |
Why?
|
Fatigue | 1 | 2023 | 1531 | 0.030 |
Why?
|
Fatal Outcome | 1 | 2020 | 1850 | 0.030 |
Why?
|
Pregnancy | 3 | 2023 | 29144 | 0.030 |
Why?
|
Cross-Cultural Comparison | 1 | 2019 | 651 | 0.030 |
Why?
|
Placebos | 1 | 2020 | 1676 | 0.030 |
Why?
|
Sensitivity and Specificity | 2 | 2020 | 14722 | 0.030 |
Why?
|
Placebo Effect | 1 | 2018 | 502 | 0.030 |
Why?
|
Menarche | 1 | 2017 | 516 | 0.030 |
Why?
|
Diet, Mediterranean | 1 | 2021 | 700 | 0.030 |
Why?
|
Reverse Transcriptase Polymerase Chain Reaction | 1 | 2022 | 4751 | 0.030 |
Why?
|
Adrenal Cortex Hormones | 1 | 2023 | 1855 | 0.030 |
Why?
|
HLA-B Antigens | 1 | 2015 | 353 | 0.030 |
Why?
|
ROC Curve | 1 | 2021 | 3527 | 0.030 |
Why?
|
Creatinine | 1 | 2018 | 1919 | 0.030 |
Why?
|
Interleukin-1beta | 1 | 2018 | 972 | 0.030 |
Why?
|
Confidence Intervals | 1 | 2018 | 2971 | 0.030 |
Why?
|
Statistics, Nonparametric | 1 | 2018 | 2886 | 0.030 |
Why?
|
Consensus | 1 | 2021 | 2959 | 0.030 |
Why?
|
Medical Informatics | 1 | 2019 | 745 | 0.030 |
Why?
|
Viral Load | 1 | 2020 | 3299 | 0.030 |
Why?
|
Fear | 1 | 2020 | 1440 | 0.020 |
Why?
|
Single-Cell Analysis | 1 | 2022 | 2183 | 0.020 |
Why?
|
Program Development | 1 | 2018 | 1316 | 0.020 |
Why?
|
Acute Disease | 1 | 2022 | 7149 | 0.020 |
Why?
|
Sulfonamides | 1 | 2020 | 1938 | 0.020 |
Why?
|
Decision Support Techniques | 1 | 2021 | 1956 | 0.020 |
Why?
|
Osteoarthritis | 1 | 2018 | 1036 | 0.020 |
Why?
|
Genomics | 2 | 2020 | 5720 | 0.020 |
Why?
|
T-Lymphocyte Subsets | 1 | 2019 | 1838 | 0.020 |
Why?
|
Cooperative Behavior | 1 | 2018 | 1504 | 0.020 |
Why?
|
Pyrazoles | 1 | 2020 | 1972 | 0.020 |
Why?
|
Pregnancy Outcome | 1 | 2020 | 2795 | 0.020 |
Why?
|
Th17 Cells | 1 | 2016 | 766 | 0.020 |
Why?
|
Interleukin-2 | 1 | 2016 | 1904 | 0.020 |
Why?
|
Anthropometry | 1 | 2014 | 1350 | 0.020 |
Why?
|
Qualitative Research | 1 | 2018 | 2682 | 0.020 |
Why?
|
Societies, Medical | 1 | 2021 | 3743 | 0.020 |
Why?
|
Haplotypes | 1 | 2015 | 2779 | 0.020 |
Why?
|
Crohn Disease | 1 | 2022 | 2303 | 0.020 |
Why?
|
Interleukin-6 | 1 | 2018 | 3200 | 0.020 |
Why?
|
RNA, Messenger | 1 | 2023 | 13033 | 0.020 |
Why?
|
Chronic Disease | 1 | 2022 | 9146 | 0.020 |
Why?
|
Energy Intake | 1 | 2014 | 2148 | 0.020 |
Why?
|
Cells, Cultured | 1 | 2022 | 19229 | 0.020 |
Why?
|
Genotype | 1 | 2020 | 12951 | 0.020 |
Why?
|
Models, Genetic | 1 | 2015 | 3494 | 0.020 |
Why?
|
Curriculum | 1 | 2018 | 3605 | 0.020 |
Why?
|
Mice, Knockout | 1 | 2018 | 14557 | 0.010 |
Why?
|
Blood Pressure | 1 | 2018 | 8554 | 0.010 |
Why?
|
Medicare | 1 | 2020 | 6566 | 0.010 |
Why?
|
Mice, Inbred C57BL | 1 | 2018 | 21827 | 0.010 |
Why?
|
Infant | 1 | 2020 | 35136 | 0.010 |
Why?
|
Stroke | 1 | 2018 | 9981 | 0.010 |
Why?
|
Diabetes Mellitus, Type 2 | 1 | 2018 | 11725 | 0.010 |
Why?
|
Mice | 1 | 2018 | 81183 | 0.010 |
Why?
|
Animals | 1 | 2018 | 168757 | 0.000 |
Why?
|